Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia

被引：72

作者：

Green, Alexa S. ^{[1
,2
,3
,4
]}

Maciel, Thiago T. ^{[5
,6
,7
,8
]}

Hospital, Marie-Anne ^{[1
,2
,3
]}

Yin, Chae ^{[9
]}

Mazed, Fetta ^{[1
,2
,3
]}

Townsend, Elizabeth C. ^{[10
]}

Pilorge, Sylvain ^{[1
,2
,3
,11
]}

Lambert, Mireille ^{[1
,2
,3
]}

Paubelle, Etienne ^{[5
,6
,7
,8
]}

Jacquel, Arnaud ^{[11
]}

Zylbersztejn, Florence ^{[5
,6
,7
,8
]}

Decroocq, Justine ^{[5
,6
,7
,8
]}

Poulain, Laury ^{[1
,2
,3
]}

Sujobert, Pierre ^{[1
,2
,3
]}

Jacque, Nathalie ^{[1
,2
,3
]}

Adam, Kevin ^{[1
,2
,3
]}

So, Jason C. C. ^{[9
]}

Kosmider, Olivier ^{[1
,2
,3
]}

Auberger, Patrick ^{[11
]}

Hermine, Olivier ^{[5
,6
,7
,8
]}

Weinstock, David M. ^{[10
]}

Lacombe, Catherine ^{[1
,2
,3
]}

Mayeux, Patrick ^{[1
,2
,3
]}

Vanasse, Gary J. ^{[12
]}

Leung, Anskar Y. ^{[9
]}

Moura, Ivan C. ^{[5
,6
,7
,8
]}

Bouscary, Didier ^{[1
,2
,3
]}

Tamburini, Jerome ^{[1
,2
,3
]}

机构：

[1] CNRS, Inst Cochin, INSERM U1016, Dept Dev Reprod Canc,UMR 8104, F-75014 Paris, France

[2] Univ Paris 05, Fac Med, Sorbonne Paris Cite, F-75005 Paris, France

[3] Ligue Natl Canc LNCC, Equipe Labellisee, F-75013 Paris, France

[4] Charles Nicolle Univ Hosp, Dept Hematol, F-76000 Rouen, France

[5] INSERM UMR 1163, Lab Cellular & Mol Mech Hematol Disorders & Thera, F-75015 Paris, France

[6] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, F-75015 Paris, France

[7] CNRS, ERL 8254, F-75015 Paris, France

[8] Lab Excellence GR Ex, F-75015 Paris, France

[9] Univ Hong Kong, Li Ka Shing LKS Fac Med, Dept Med, Div Hematol, Hong Kong, Hong Kong, Peoples R China

[10] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[11] INSERM U1065, C3M Team 2, Cell Death Differentiat Inflammat & Canc, F-06204 Nice, France

[12] Novartis Inst BioMed Res, Cambridge, MA 02139 USA

来源：

SCIENCE ADVANCES | 2015年 / 1卷 / 08期

关键词：

D O I：

10.1126/sciadv.1500221

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) is frequently detected in acute myeloid leukemia (AML) patients and is associated with a dismal long-term prognosis. FLT3 tyrosine kinase inhibitors provide shortterm disease control, but relapse invariably occurs within months. Pim protein kinases are oncogenic FLT3-ITD targets expressed in AML cells. We show that increased Pim kinase expression is found in relapse samples from AML patients treated with FLT3 inhibitors. Ectopic Pim-2 expression induces resistance to FLT3 inhibition in both FLT3ITD- induced myeloproliferative neoplasm and AML models in mice. Strikingly, we found that Pim kinases govern FLT3-ITD signaling and that their pharmacological or genetic inhibition restores cell sensitivity to FLT3 inhibitors. Finally, dual inhibition of FLT3 and Pimkinases eradicates FLT3-ITD+ cells including primary AML cells. Concomitant Pim and FLT3 inhibition represents a promising new avenue for AML therapy.

引用

页数：13

共 50 条

[41] Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemia
K Reiter
H Polzer
C Krupka
A Maiser
B Vick
M Rothenberg-Thurley
K H Metzeler
D Dörfel
H R Salih
G Jung
E Nößner
I Jeremias
W Hiddemann
H Leonhardt
K Spiekermann
M Subklewe
P A Greif
Leukemia, 2018, 32 : 313 - 322
[42] Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemia
Reiter, K.
Polzer, H.
Krupka, C.
Maiser, A.
Vick, B.
Rothenberg-Thurley, M.
Metzeler, K. H.
Doerfel, D.
Salih, H. R.
Jung, G.
Noessner, E.
Jeremias, I.
Hiddemann, W.
Leonhardt, H.
Spiekermann, K.
Subklewe, M.
Greif, P. A.
LEUKEMIA, 2018, 32 (02) : 313 - 322
[43] Dual Inhibition of FLT3 and AXL by Gilteritinib Overcomes Hematopoietic Niche-Driven Resistance Mechanisms in FLT3-ITD Acute Myeloid Leukemia
Dumas, Pierre-Yves
Villacreces, Arnaud
Guitart, Amelie V.
El-habhab, Ali
Massara, Layal
Mansier, Olivier
Bidet, Audrey
Martineau, Delphine
Fernandez, Solene
Leguay, Thibaut
Pigneux, Arnaud
Vigon, Isabelle
Pasquet, Jean-Max
Desplat, Vanessa
CLINICAL CANCER RESEARCH, 2021, 27 (21) : 6012 - 6025
[44] Shikonin exerts an anti-leukemia effect against FLT3-ITD mutated acute myeloid leukemia cells via targeting FLT3 tyrosine kinase and its downstream pathways
Zhao, Mu-Nan
Su, Long
Song, Fei
Wei, Zhi-Feng
Qin, Tian-Xue
Zhang, Yun-Wei
Li, Wei
Gao, Su-Jun
ACTA HAEMATOLOGICA, 2023, : 310 - 323
[45] Effects of PP2A-activating drugs on FLT3 inhibitor resistance mediated by diverse mechanisms in acute myeloid leukemia with FLT3-ITD
Ali, Moaath Mustafa
Chatterjee, Aditi
Lee, Jonelle K.
Scarpa, Mario
Baer, Maria R.
CANCER RESEARCH, 2023, 83 (07)
[46] Dual inhibition of CHK1/FLT3 enhances cytotoxicity and overcomes adaptive and acquired resistance in FLT3-ITD acute myeloid leukemia
Jiang, Kailong
Li, Xuemei
Wang, Chang
Hu, Xiaobei
Wang, Peipei
Tong, Lexian
Tu, Yutong
Chen, Beijing
Jin, Tingting
Wang, Tao
Wang, Hanlin
Han, Yubing
Gui, Renzhao
Yang, Jianmin
Liu, Tao
Li, Jia
Zhou, Yubo
LEUKEMIA, 2023, 37 (03) : 539 - 549
[47] FLT3 tyrosine kinase inhibitors
Levis, M
Small, D
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 82 (02) : 100 - 107
[48] Impact of FLT3-ITD length on prognosis of acute myeloid leukemia
Liu, Song-Bai
Dong, Hao-Jie
Bao, Xie-Bing
Qiu, Qiao-Cheng
Li, Hong-Zhi
Shen, Hong-Jie
Ding, Zi-Xuan
Wang, Chao
Chu, Xiao-Ling
Yu, Jing-Qiu
Tao, Tao
Li, Zheng
Tang, Xiao-Wen
Chen, Su-Ning
Wu, De-Pei
Li, Ling
Xue, Sheng-Li
HAEMATOLOGICA, 2019, 104 (01) : E9 - E12
[49] Mechanisms Underlying Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia
Eguchi, Motoki
Minami, Yosuke
Kuzume, Ayumi
Chi, SungGi
BIOMEDICINES, 2020, 8 (08)
[50] Dual inhibition of CHK1/FLT3 enhances cytotoxicity and overcomes adaptive and acquired resistance in FLT3-ITD acute myeloid leukemia
Kailong Jiang
Xuemei Li
Chang Wang
Xiaobei Hu
Peipei Wang
Lexian Tong
Yutong Tu
Beijing Chen
Tingting Jin
Tao Wang
Hanlin Wang
Yubing Han
Renzhao Gui
Jianmin Yang
Tao Liu
Jia Li
Yubo Zhou
Leukemia, 2023, 37 : 539 - 549

← 1 2 3 4 5 →